News
Every year, millions of infants are infected by a little-known virus that is the most common cause of respiratory disease in children. Respiratory syncytial ... the pattern of predictable ...
In a recent final analysis of a phase 3 trial, the bivalent respiratory syncytial virus prefusion F (RSVpreF) vaccine maintained high efficacy and a favorable safety profile against RSV-associated ...
4mon
The Healthy @Reader's Digest on MSNThe Covid Booster and Flu Shot: Can You Get Both at Once? Doctors’ Advice for 2023-2024Learn what virus specialists recommend as you head out for your seasonal vaccinations: "This is a small price to pay for protection," a leading infectious disease doctor says.
As temperatures drop, the flu and respiratory syncytial virus (RSV ... the timing of these illnesses is tied to weather and seasonal patterns. "It's unique every year; we see it hit at a different ...
Adults diagnosed with RSV-associated acute respiratory infection face nearly triple the risk of death within 1 year compared ...
Enanta Pharmaceuticals Announces Respiratory Syncytial Virus Data Presentation at ESCMID Global 2025
Enanta’s clinical programs are currently focused on respiratory syncytial virus (RSV) and its earlier-stage immunology pipeline aims to develop treatments for inflammatory diseases by targeting ...
A study reveals that Respiratory Syncytial Virus-associated Acute Respiratory Infection increases death risk in adults. The risk is three times higher within a year. RSV can lead to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results